CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totaling 39,741 shares, a drop of 83.9% from the May 31st total of 246,664 shares. Based on an average daily volume of 8,338,945 shares, the short-interest ratio is presently 0.0 days.
CBD Life Sciences Stock Performance
Shares of CBDL stock opened at $0.00 on Friday. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.00.
CBD Life Sciences Company Profile
CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.
The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.
Featured Articles
- Five stocks we like better than CBD Life Sciences
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
- MarketBeat Week in Review – 06/22 – 06/26
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
